Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

To collect the safety and effectiveness data of flow-di in the treatment of intracranial aneurysms in real-world clinical practice, verify its classification of treatment strategies for aneurysms of different locations and shapes, and optimize postoperative medication regimen, provide long-term evidence-based basis for clinical treatment of intracranial aneurysms, and build a database.

NCT Number	NCT06943729
Lead Sponsor	Huashan Hospital Collaborators: Xinqiao Hospital of Chongqing, Ningbo No.2 Hospital, Eighth Affiliated Hospital, Sun Yat-sen University, Second Affiliated Hospital of Nanchang University, Jiangxi Provincial People's Hopital, Zhengzhou Central Hospital, Xuchang Central Hospital, Second People's Hospital of Hunan, People's Hospital Of Ningxiang City, The First People's Hospital of Changde City, HUANG GANG Central Hospital, Xianning Central Hospital, Jingzhou Central Hospital, Yichang Central People's Hospital, The First People's Hospital of Changzhou, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Northern Jiangsu People's Hospital, Suzhou Municipal Hospital, Jiangsu Taizhou People's Hospital, Huadong Hospital, RenJi Hospital, Shanghai Zhongshan Hospital, Shanghai Fourth People's Hospital, Shanghai Donglei Brain Hospital, Shanghai Pudong New Area People's Hospital, Shanghai East Hospital of Tongji University, First Affiliated Hospital Xi'an Jiaotong University, Second Affiliated Hospital of Xi'an Jiaotong University, Tangshan Gongren Hospital, The Second Hospital of Hebei Medical University, Hebei General Hospital, Xingtai People's Hospital, Peking University First Hospital, THE AFFILIATED SUZHOU HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL, The Second Affiliated Hospital of Kunming Medical University
Conditions	Flow Diverter
Enrollment	523 participants
Start Date	2025-04-27
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-08-29